Assertio Holdings (ASRT) Non-Current Debt (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Non-Current Debt came in at $39.2 million in Q1 2026, up 0.82% year-on-year from $38.9 million in Q1 2025, and little changed quarter-over-quarter from $39.1 million in Q4 2025.
Assertio Holdings (ASRT) Non-Current Debt (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Non-Current Debt across 8 years of filings, most recently posting $39.2 million for Q1 2026.
- Non-Current Debt for Q1 2026 came in at $39.2 million, up 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.2 million (up 0.82% YoY), and the FY2025 annual result was $39.1 million, up 0.8% from the prior year.
- Non-Current Debt came in at $39.2 million for Q1 2026 at Assertio Holdings, roughly flat from $39.1 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $66.4 million in Q4 2022 to a low of $38.2 million in Q1 2023.
- The 5-year median for Non-Current Debt is $38.9 million (2025), against an average of $44.0 million.
- Across the five-year window, Non-Current Debt gained 8.29% in 2022 and slumped 42.0% in 2023, its largest moves.
- Assertio Holdings' Non-Current Debt stood at $66.4 million in 2022, then plunged by 42.0% to $38.5 million in 2023, then advanced by 0.78% to $38.8 million in 2024, then gained by 0.8% to $39.1 million in 2025, then gained by 0.32% to $39.2 million in 2026.
- The last three Non-Current Debt figures came in at $39.2 million (Q1 2026), $39.1 million (Q4 2025), and $39.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 39.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.25 Mn |
| Mar 31, 2026 | 39.25 Mn |
| Dec 31, 2025 | 39.12 Mn |
| Dec 31, 2025 | 39.12 Mn |
| Sep 30, 2025 | 39.17 Mn |
| Sep 30, 2025 | 39.17 Mn |
| Jun 30, 2025 | 39.05 Mn |
| Jun 30, 2025 | 39.05 Mn |
| Mar 31, 2025 | 38.93 Mn |
| Mar 31, 2025 | 38.93 Mn |
| Dec 31, 2024 | 38.81 Mn |
| Dec 31, 2024 | 38.81 Mn |
| Sep 30, 2024 | 38.84 Mn |
| Sep 30, 2024 | 38.84 Mn |
| Jun 30, 2024 | 38.73 Mn |
| Jun 30, 2024 | 38.73 Mn |
| Mar 31, 2024 | 38.62 Mn |
| Mar 31, 2024 | 38.62 Mn |
| Dec 31, 2023 | 38.51 Mn |
| Dec 31, 2023 | 38.51 Mn |